Clinical Trial

Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the efficacy and tolerability of a platinum-based regimen combined with the PD-1 antibody toripalimab administered prior to concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
Trial Details
NCT Number NCT07092696
Lead Sponsor Tianjin Medical University Cancer Institute and Hospital
Conditions Cervical Cancer
Enrollment 34 participants
Start Date 2024-12-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-30